Retatrutide
Triple agonist (GLP-1/GIP/Glucagon) under investigation for weight management and metabolic optimization. Animal studies show enhanced fat oxidation and energy expenditure.
Category: Research Peptides
Brand: BioBoost Labs+™
Retatrutide is a novel investigational peptide and multi-receptor agonist designed to target the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Its unique triple agonist action makes it of significant interest in research focused on metabolic health, including weight management, glucose regulation, and related metabolic disorders.
Retatrutide is intended strictly for laboratory research use. It is commonly used in studies investigating metabolic regulation, obesity and weight loss, glucose homeostasis, and the interplay of multiple metabolic hormones in experimental models.
This product is sold strictly for research use only. It is not intended for human consumption, medical diagnosis, treatment, or therapy. By purchasing this product, you agree to use it solely for laboratory research and development purposes.
COAS:
- BioBoost Labs Retatrutide 15mg 99.80%
- BioBoost Labs Retatrutide 10mg (1st test)
- BioBoost Labs Retatrutide 99.08%
- COA 250960 QC251134 Retatrutide 15mg
- COA251337 QC251460 Retatrutide 15
- COA251338 QC251461 Retatrutide 15mg
- COA 250779 QC250953 Retatrutide 15mg MDx
- COA251671E QC251730 Retatrutide15mg
- COA251671 QC251730 Retatrutide15mg
- COA251670E QC251729 Retatrutide20mg
- COA251670 QC251729 Retatrutide20mg
Key Features:
- Peptide Type: Triple receptor agonist (GLP-1, GIP, and glucagon receptors)
- Molecular Formula: [Proprietary/Varies based on supplier]
- CAS Number: 2831062-38-1
- Purity: >99% (HPLC)
- Form: Lyophilized powder
This product is not a drug, and it has not been approved by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease.
